跳至主要内容
临床试验/NL-OMON54741
NL-OMON54741招募中不适用

Aspin: Neurosurgical Aspirin Intervention Prognostic Study; perioperative continuation versus discontinuation of aspirin in spinal surgery, a randomized controlled, noninferiority trial. - Aspin: Neurosurgical Aspirin Intervention Prognostic Study

Haaglanden Medisch Centrum0 个研究点目标入组 554 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
554

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Elective spinal surgery
  • Pre-operative use of aniplatelet drugs
  • Pre-operative use of aspirin

排除标准

  • Spinal oncology
  • Staged surgeries lasting more than one day
  • Patients with a pre-existing coagulopathy
  • Patients using antithrombotic drugs or other platelet aggregation inhibitors
  • than aspirin
  • Patients with absolute contraindication for discontinuing aspirin (e.g.
  • coronary stenting within 1 year)
  • Patients aged under 18
  • Emergency surgical procedures
  • Incompetence to decide, i.e. in case of severe cognitive impairment or
  • psychiatric illness.

研究者

相似试验

Aspin: Neurosurgical Aspirin Intervention Prognostic... | 临床试验